Neko Health, which offers AI-based full-body scans and was co-founded by Daniel Ek and Hjalmar Nilsonne, launches in London, its first city outside Sweden
Context & Ripple Effects
Neko Health emerged from stealth in 2023 with plans for an AI-powered full-body scanner, making London a shift from product development to operating the service in a new market. Its earlier stealth exit around the scanner concept established the company’s preventive-health positioning.
The London opening is the company’s first move beyond Sweden, following its €60M funding round in 2023. It matters because the offering depends on deploying a physical service, not merely distributing software.
First-order effects
- London residents can now access Neko Health’s AI-based full-body scan service, while the company must establish local operations outside its home market.
- Neko Health moves from a Sweden-only footprint to managing service delivery across two national markets.
Second-order effects
- The expansion tests whether Neko Health can reproduce its operating model in a larger city, including the practical demands of staffing, sites, and customer acquisition.
- Other preventive-health and diagnostic-service providers in London face a new AI-led full-body-scan option competing for health-conscious consumers’ attention.
Third-order effects
- If Neko can repeat this rollout, AI health startups with physical touchpoints may be judged increasingly on multi-city execution rather than on their models alone.
- The move is an early test of whether preventive screening can become a scalable, cross-border consumer health-service category; that outcome remains dependent on operational replication.
The trend: AI health companies are moving from developing diagnostic tools to building location-based consumer services around preventive screening.